|
Report Date : |
13.07.2012 |
IDENTIFICATION DETAILS
|
Correct Name : |
BUSSAN BIOTECH CO LTD |
|
|
|
|
Registered Office : |
Shiba Nichome
Daimon Bldg, 2-3-3 Shiba Minatoku |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2012 |
|
|
|
|
Date of Incorporation : |
April
1995 |
|
|
|
|
Com. Reg. No.: |
0104-01-026058 (Tokyo-Minatoku)) |
|
|
|
|
Legal Form : |
Limited
Company |
|
|
|
|
Line of Business : |
Import,
export, wholesale of feed additives, pharmaceutical intermediates |
|
|
|
|
No. of Employees : |
40 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BUSSAN BIOTECH CO LTD
Bussan Biotech KK
Shiba Nichome
Daimon Bldg, 2-3-3 Shiba Minatoku Tokyo 105-8181 JAPAN
Tel:
03-5418-8181 Fax: 03-5418-8165
URL: http://www.bussan-bio.co.jp
E-Mail address: (thru URL)
Import,
export, wholesale of feed additives, pharmaceutical intermediates
Nil
YOSHIMASA
KAWAMURA, PRES Akihisa
Kaneko, s/mgn dir
Masao
Kitamura, mgn dir Hideyuki
Murakami, dir
Masatoshi
Yamaguchi, dir Hiroaki
Saiga, dir
Yen
Amount: In million Yen, unless
otherwise stated
FINANCES FAIR A/SALES Yen 3,700 M
PAYMENTS No
Complaints CAPITAL Yen 100 M
TREND SLOW WORTH Yen 721 M
STARTED 1995 EMPLOYES 40
TRADING FIRM SPECIALIZING IN FEED
ADDITIVES & PHARMACEUTICAL
IMTERMEDIATES, AFFILIATED TO MITSUI & CO LTD.
FINANCIAL
SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY
BUSINESS ENGAGEMENTS.
The subject company was established on the basis of a material division separated from Mitsui & Co Ltd (See REGISTRATION). This is a trading firm specializing in import, export and wholesale of feed additives & pharmaceutical intermediates. Imports are centrally from USA. Clients include chemical firms, farmers, other, nationwide.
The sales volume for Mar/2011 fiscal term amounted to Yen 3,700 million, a 3% down from Yen 3,800 million in the previous term. The net profit was posted at Yen 133 million, compared with Yen 163 million a year ago.
For the term that ended Mar 2012 the net profit was projected at Yen 135 million, on a 3% rise in turnover, to Yen 3,800 million. Final results are yet to be released.
The financial situation is considered FAIR and good for ORDINARY business engagements.
Date Registered: Apr
1995
Regd No.: 0104-01-026058 (Tokyo-Minatoku))
Legal Status:
Limited Company (Kabushiki Kaisha)
Authorized:
2,000 shares
Issued:
2,000 shares
Sum: Yen 100
million
Major shareholders (%): Mitsui & Co*(75), MP Agro
(10), Sun Daicoo (5), Morikubo Yakuhin (5), other
No. of shareholders: 5
* Leading general trading house vying with Mitsubishi Corp for top position, Tokyo, founded 1947, listed Tokyo, Osaka, Fukuoka, Sapporo, NASDAQ, capital Yen 341,482 million, turnover Yen 10,481,160 million, operating profit yen 348,384 million, recurring profit Yen 413,211 million, net profit Yen 434,497 million, total assets Yen 9,011,823 million, net worth Yen 2,641,328, employees 44,937, pres Masami Iijima
Consolidated
Financials are attached (See SUPPLEMENTS)
Nothing detrimental is known as
to the commercial morality of executives.
Activities: Imports, exports and wholesales feed additives, pharmaceutical intermediates, others (--100%).
Clients: [Pharmaceutical makers, farm coops] Maruzen Yakuhin Corp, Sun Daico, Nutritec Co, Morikubo Yakuhin, Marubeni Nisshin Feed, Nippon Formula Feed Mfg, Everlth Agrotech, MP Agro, Bayer Pharmaceuticals, Scientific Feed Laboratory, other.
No. of accounts: 500
Domestic areas of activities: Nationwide
Suppliers: [Mfrs, wholesalers] Mitsui & Co, Ortek Corp, Nutritec Co, Scientific Feed Laboratory, DSM Nutrition Japan, Nippon Formula Feed Mfg, Marubeni Nisshin Feed, other.
Payment record: No Complaints
Location: Business area in Tokyo. Office premises at the caption address are leased and maintained satisfactorily.
Bank References:
SMBC
(Hamamatsucho)
MUFG
(Tamachi)
Relations:
Satisfactory
(In Million Yen)
|
Terms Ending: |
31/03/2012 |
31/03/2011 |
31/03/2010 |
31/03/2009 |
|
|
Annual
Sales |
|
3,800 |
3,700 |
3,800 |
3,600 |
|
Recur.
Profit |
|
|
|
|
|
|
Net
Profit |
|
135 |
133 |
163 |
146 |
|
Total
Assets |
|
|
1,245 |
1,514 |
1,411 |
|
Current
Assets |
|
|
1,173 |
1,487 |
1,384 |
|
Current
Liabs |
|
|
465 |
820 |
811 |
|
Net
Worth |
|
|
721 |
670 |
578 |
|
Capital,
Paid-Up |
|
|
100 |
100 |
100 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
2.70 |
-2.63 |
5.56 |
2.92 |
|
|
Current Ratio |
|
.. |
252.26 |
181.34 |
170.65 |
|
N.Worth Ratio |
.. |
57.91 |
44.25 |
40.96 |
|
|
R.Profit/Sales |
|
.. |
.. |
.. |
.. |
|
N.Profit/Sales |
3.55 |
3.59 |
4.29 |
4.06 |
|
|
Return On Equity |
.. |
18.45 |
24.33 |
25.26 |
|
Notes:
Forecast (or estimated) figures for the 31/03/2012 fiscal term.
SUPPLEMENTS
CONSOLIDATED FINANCIALS OF THE PARENT,
MITSUI & CO LTD
|
FINANCES: (Consolidated
in million yen) |
|
|||||
|
|
|
Terms Ending: |
31/03/2012 |
31/03/2011 |
||
|
INCOME STATEMENT |
|
|
||||
|
|
Annual Sales |
|
10,481,166 |
9,942,472 |
||
|
|
Cost of Sales |
9,602,887 |
9,083,249 |
|||
|
|
GROSS PROFIT |
878,279 |
859,223 |
|||
|
|
Selling & Adm Costs |
529,895 |
542,220 |
|||
|
|
OPERATING PROFIT |
348,384 |
317,003 |
|||
|
|
Non-Operating P/L |
64,837 |
-44,306 |
|||
|
|
RECURRING PROFIT |
413,221 |
272,697 |
|||
|
|
NET PROFIT |
434,497 |
306,659 |
|||
|
BALANCE SHEET |
|
|
|
|||
|
|
Cash |
|
1,431,112 |
1,441,059 |
||
|
|
Receivables |
|
1,616,191 |
1,463,601 |
||
|
|
Inventory |
|
515,758 |
467,355 |
||
|
|
Securities, Marketable |
1,087 |
5,602 |
|||
|
|
Other Current Assets |
862,175 |
940,025 |
|||
|
|
TOTAL CURRENT ASSETS |
4,426,323 |
4,317,642 |
|||
|
|
Property & Equipment |
2,265,334 |
1,930,994 |
|||
|
|
Intangibles |
|
110,307 |
87,525 |
||
|
|
Investments, Other Fixed Assets |
2,209,859 |
2,261,963 |
|||
|
|
TOTAL ASSETS |
9,011,823 |
8,598,124 |
|||
|
|
Payables |
|
1,342,343 |
1,316,772 |
||
|
|
Short-Term Bank Loans |
307,132 |
250,062 |
|||
|
|
|
|
|
|
||
|
|
Other Current Liabs |
974,555 |
976,115 |
|||
|
|
TOTAL CURRENT LIABS |
2,624,030 |
2,542,949 |
|||
|
|
Debentures |
|
|
|
||
|
|
Long-Term Bank Loans |
2,898,218 |
2,818,529 |
|||
|
|
Reserve for Retirement Allw |
55,799 |
37,054 |
|||
|
|
Other Debts |
|
572,966 |
646,268 |
||
|
|
TOTAL LIABILITIES |
6,151,013 |
6,044,800 |
|||
|
|
MINORITY INTERESTS |
|
|
|||
|
|
Common
stock |
341,482 |
341,482 |
|||
|
|
Additional
paid-in capital |
430,491 |
430,152 |
|||
|
|
Retained
earnings |
2,192,494 |
1,860,271 |
|||
|
|
Evaluation
p/l on investments/securities |
90,476 |
96,657 |
|||
|
|
Others |
|
(187,930) |
(168,887) |
||
|
|
Treasury
stock, at cost |
(6,203) |
(6,341) |
|||
|
|
TOTAL S/HOLDERS` EQUITY |
2,860,810 |
2,553,334 |
|||
|
|
TOTAL EQUITIES |
9,011,823 |
8,598,124 |
|||
|
CONSOLIDATED CASH FLOWS |
|
|
||||
|
|
|
Terms ending: |
31/03/2012 |
31/03/2011 |
||
|
|
Cash
Flows from Operating Activities |
|
380,984 |
504,474 |
||
|
|
Cash Flows
from Investment Activities |
-438,191 |
-484,021 |
|||
|
|
Cash
Flows from Financing Activities |
57,394 |
33,820 |
|||
|
|
Cash,
Bank Deposits at the Term End |
|
1,431,112 |
1,441,059 |
||
|
ANALYTICAL RATIOS Terms ending: |
31/03/2012 |
31/03/2011 |
||||
|
|
|
Net
Worth (S/Holders' Equity) |
2,860,810 |
2,553,334 |
||
|
|
|
Current
Ratio (%) |
168.68 |
169.79 |
||
|
|
|
Net
Worth Ratio (%) |
31.75 |
29.70 |
||
|
|
|
Recurring
Profit Ratio (%) |
3.94 |
2.74 |
||
|
|
|
Net
Profit Ratio (%) |
4.15 |
3.08 |
||
|
|
|
Return
On Equity (%) |
15.19 |
12.01 |
||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.70 |
|
UK Pound |
1 |
Rs.86.28 |
|
Euro |
1 |
Rs.68.15 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.